National
Out-of-state activists headed to N.C. to fight amendment
Volunteers ready to staff phone banks, boost turnout for Tuesday vote
K. Travis Ballie (Blade photo by Michael Key)
For K. Travis Ballie, helping with the campaign against Amendment One in North Carolina represents a chance to reverse the losses on state ballot initiatives in the more than 30 states that have seen votes on marriage equality.
“I’m going down because 2012 is a very unique year, even since 2004, when we saw the greatest number of marriage amendments on the ballot, we didn’t defeat any of them,” Ballie said. “Now in 2012, we have an anti-marriage amendment on the ballot in a southern state, in North Carolina, which also happens to be one of the most important swing states in this election cycle.”
Ballie, a gay 23-year-old Silver Spring, Md., resident, said he’s personally invested in the fight against the anti-gay measure — which will come before state voters Tuesday and would make a ban on same-sex marriage part of the state constitution — because he has gay friends in North Carolina, including one who had a marriage ceremony in the state a few weeks ago.
“This is really her marriage on the ballot,” Ballie said. “When there are people like Hillary that are in North Carolina that are just pleading for help from activists across the country, the only moral response is to go down to North Carolina and really help defeat this amendment.”
Ballie said challenging anti-gay amendments wherever they emerge across the country is important.
“I think we’re at a point where our community understands that we need to put up a fight wherever an amendment happens, be it a Southern state, be it the Northeast, anywhere in the country,” Ballie said. “These amendments are politically feasible to be defeated and even if we lose, which we won’t, we are really orchestrating one of the largest LGBT-focused statewide campaigns in North Carolina, one of the fastest growing states in our country.”
Ballie is one of several LGBT rights supporters — coming from places like D.C., Sacramento and Chicago — who are expected to travel to North Carolina to help in the campaign against Amendment One.
Another D.C.-area resident, Bryan Oklin, a gay 28-year-old attorney, said he also intends to travel to North Carolina to participate in efforts against Amendment One, calling it a “misguided, divisive measure,” because of the negative effect it would have on LGBT families.
“It seeks to enshrine in the North Carolina state Constitution that one group of the state’s citizens deserves less civil rights than all others,” Oklin said. “It is a backwards, bigoted initiative reminiscent of a past, less tolerant period of time.”
Same-sex marriage is already barred by statute in North Carolina. Opponents say the measure would not only make that ban part of the state constitution, but also prohibit civil unions and interfere with domestic partner benefits offered by municipalities as well as threaten contractual arrangements between same-sex partners.
Adam Bink, director of online programs for the Courage Campaign and an organizer for grassroots efforts against Amendment One, said the Coalition to Protect All NC Families, the campaign against Amendment One, will have more than 100 volunteers coming from out of state either through their signup form or through the Human Rights Campaign. On top of that, Courage Campaign will bring in 15 additional supporters.
“We’ll be putting volunteers to work at phone banks, events like OutRaleigh 2012 this weekend, and going to doors to talk to voters and leave reminders to vote across college campuses and in neighborhoods,” Bink said. “They’ll be focused on one core mission: ensuring we get our supporters to the polls.”
Bink said the out-of-state efforts that helped lead to the passage of California’s Proposition 8 are a stark reminder of why outside support can be important.
“Courage Campaign members from across the country wrote in to tell us they’re going because don’t want to leave any state behind, and because they understand that Amendment 1 goes too far in hurting families across North Carolina,” Bink said. “Our members will never forget the busloads of volunteers from outside California that helped pass Prop 8. We’ve learned from that experience.”
It’s this memory of Prop 8 that is motivating Amanda Wallner, a 24-year-old lesbian from Sacramento, Calif., to travel to North Carolina. For her, the memory of the passage of Prop 8 in 2008 as a college student and the rescinding of the marriage law in Maine in 2009 — which she helped fight — both weigh heavily on her.
“The loss of the ‘No on 8’ campaign hit me really hard,” Wallner said. “When we lost, I could barely get out of bed the next day. I still get emotional sometimes when I read about it. Any opportunity that I have to apply some of the lessons that I learned during that campaign to help out other LGBT people — I’m really excited to have the opportunity.”
Wallner added that going door-to-door explaining the harm of anti-gay amendments brings the biggest gains for the LGBT movement.
“That’s one of the reasons that I love electoral campaigns so much,” Wallner said. “It gives me that opportunity to talk to people face to face, and for them to be able to put a face to the issue.”
These activists could face an uphill battle; polls have shown majority support for the amendment, though there has been a shift in momentum in recent weeks.
Larry Sabato, a political scientist at the University of Virginia, said he thinks the amendment is likely to pass as similar marriage amendments have in the past.
“I couldn’t guess the margin at the moment, but it is hard to see how it fails to garner a majority ‘yes’ vote,” Sabato said. “The usual patterns are emerging: Seniors are strongly in favor and young people are the least likely to back it, Democrats are opposed while Republicans support.”
Even so, the pro-LGBT side in the race has a funding advantage over proponents of the anti-gay amendment. According to media reports, the Coalition to Protect All NC Families has raised $2.3 million to date and has $294,000 in cash on hand, while Vote for Marriage NC has raised a total of $1.2 million and has $112,000 in cash on hand. The pro-LGBT side is touting that individual small donations make up the bulk of its funds, while large contributions from the Christian Action League and the National Organization for Marriage made up the other side.
Moreover, recent polling shows support for the marriage amendment is declining. Data published last week by Public Policy Polling found only 54 percent of voters in the state plan to vote for it, while 40 percent are opposed to the measure. That’s the lowest level of support for the measure that PPP has found in polling since last October.
Bink said the decline in support for the North Carolina amendment shows the pro-LGBT side is within “striking distance” of victory.
“What’s more, the same poll shows that the more North Carolinians learn what Amendment One does, the less they support it, which is why an original 27-point lead has been cut in half,” Bink said. “A supermajority of North Carolinians oppose a constitutional amendment that bans same-sex marriage as well as civil unions and domestic partnerships for unmarried couples of any gender, endangers domestic violence laws, and takes benefits like health insurance away from children of unmarried couples.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Looking back at the 10 biggest A&E stories of 2025
Kazakh president signs anti-LGBTQ propaganda bill
Top 10 LGBTQ local news stories of 2025
The 25 greatest queer movies of the 21st century so far
How to cope when a partner gives you the silent treatment
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
